Header

About Us

Sabin Vaccine Institute (Sabin) is a non-profit, 501(c)(3) organization made up of scientists, researchers, and advocates dedicated to reducing needless human suffering from vaccine preventable and neglected tropical diseases. Sabin works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the world’s most pervasive health care challenges.

Since its founding in 1993 in honor of the oral polio vaccine developer, Dr. Albert B. Sabin, the Institute has been at the forefront of efforts to control, treat, and eliminate vaccine preventable and neglected tropical diseases by developing new vaccines, advocating use of existing vaccines, and promoting increased access to affordable medical treatments.

Sabin was founded on the legacy and global vision of one of medicine’s most pre-eminent scientific figures, Dr. Albert B. Sabin, who is best known for developing the oral live virus polio vaccine. Dr. Sabin not only dedicated his entire professional career to groundbreaking medical advancements to reduce human suffering, he also waged a tireless and lifelong campaign against poverty and ignorance.

Sabin works to provide greater access to vaccines and essential treatments for hundreds of millions of people stuck in a cycle of pain, poverty and despair. Sabin’s three main programs – Sabin Vaccine Development, the Global Network for Neglected Tropical Diseases, and Vaccine Advocacy and Education – strive to uphold Dr. Sabin’s lifelong efforts by developing preventative measures for diseases that place burdens on the world's poorest countries.

Sabin’s diverse partnerships are key to our efforts to fulfill the organization’s mission. Sabin is proud of its long-standing, successful collaboration with The George Washington University (GW). Our two independent organizations have successfully worked together on many endeavors in recent years and GW has been a pivotal partner in Sabin’s vaccine development program since 2000. Sabin’s partnership with GW and other international organizations created the first-ever vaccine development program against human hookworm infection, a devastating disease that affects over 570 million people around the world. This and other partnerships with groups such as the Bill & Melinda Gates Foundation, governments, academic institutions, scientists, medical professionals, and non-profit organizations are critical in furthering the development of strategies to reduce human suffering from devastating vaccine preventable and neglected tropical diseases.

The Sabin Mission

To reduce needless human suffering from vaccine preventable and neglected tropical diseases through innovative vaccine research and development; and to advocate for improved access to vaccines and essential medicines for citizens around the globe.